Ovarian sex cord-stromal tumors in patients with probable or confirmed germline DICER1 mutations

International Journal of Gynecological Pathology

Volumn 34, Issue 3, 2015, Pages 266-274

  Oost, E Ebo ^a   Charles, Adrian ^a   Choong, Catherine S ^a   Leung, Yee C ^b   Salfinger, Stuart ^b   Sonnendecker, Hein ^a   Tan, Jason ^b   Townshend, Sharron ^c   Witkowski, Leora ^d,e   Foulkes, William D ^d,e   Stewart, Colin J R ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c KING EDWARD MEMORIAL HOSPITAL   (Australia)

^d MCGILL UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

DICER1; Granulosa cell tumor; Mutation; Ovary; Sertoli Leydig cell tumor; Sex cord stromal tumor

Indexed keywords

CALRETININ; HORMONE RECEPTOR; INHIBIN; STEROIDOGENIC FACTOR 1; DEAD BOX PROTEIN; DICER1 PROTEIN, HUMAN; RIBONUCLEASE III; TUMOR MARKER;

ADOLESCENT; ADULT; ANDROBLASTOMA; ARTICLE; CLINICAL ARTICLE; DICER1 GENE; FAMILY; FEMALE; GENE MUTATION; GERMLINE MUTATION; GRANULOSA CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERTOLI CELL; SEX CORD TUMOR; TUMOR DIFFERENTIATION; GENETICS; OVARY TUMOR; PATHOLOGY;

ADOLESCENT; ADULT; BIOMARKERS, TUMOR; DEAD-BOX RNA HELICASES; FEMALE; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; RIBONUCLEASE III; SEX CORD-GONADAL STROMAL TUMORS;

EID: 84928486556     PISSN: 02771691     EISSN: 15387151     Source Type: Journal    
DOI: 10.1097/PGP.0000000000000150     Document Type: Article

References (28)

1. Roth LM. Recent advances in the pathology and classification of ovarian sex cord-stromal tumors. Int J Gynecol Pathol 2006;25:199-215.
2. Lim GSD, Oliva E. Sex cord stromal tumors of the ovary. In: Soslow RA, Tornos C, eds. Diagnostic Pathology of Ovarian Tumors. New York: Springer-Verlag; 2011:193-234.
3. Seidman JD. Unclassified ovarian gonadal stromal tumors. A clinicopathologic study of 32 cases. Am J Surg Pathol 1996;20:699-706.
4. Stewart CJR, Alexiadis M, Crook M, et al. An immunohistochemical and molecular analysis of problematic and unclassified ovarian sex cord-stromal tumors. Hum Pathol 2013;44:2774-81.
5. Wilkinson N, Osborn S, Young RH. Sex cord-stromal tumours of the ovary: a review highlighting recent advances. Diagn Histopathol 2008;14:389-400.
6. Shah SP, Kobel M, Senz J, et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Eng J Med 2009;360:2719-29.
7. Jamieson S, Butzow R, Andersson N, et al. The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary. Mod Pathol 2010;23:1477-85.
8. Heravi-Moussavi A, Anglesio M, Cheng S, et al. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med 2012;366:234-44.
9. Witkowski L, Mattina J, Schonberger S, et al. DICER1 hotspot mutations in non-epithelial gonadal tumours. Br J Cancer 2013;109:2744-50.
10. Hill DA, Ivanovich J, Priest JR, et al. DICER1 mutations in familial pleuropulmonary blastoma. Science 2009;325:965. doi:10.1126/science.1174334.
11. Slade I, Bacchelli C, Davies H, et al. DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome. J Med Genet 2011;48:273-8.
12. Schultz KA, Yang J, Doros L, et al. DICER1-pleuropulmonary blastoma familial tumor predisposition syndrome: a unique constellation of neoplastic conditions. Pathol Case Rev 2014;19:90-100.
13. Choong CS, Priest JR, Foulkes WD. Exploring the endocrine manifestations of DICER1 mutations. Trends Mol Med 2012;18:503-5.
14. Wu MK, Sabbaghian N, Xu B, et al. Biallelic DICER1 mutations occur in Wilms tumours. J Pathol 2013;230: 154-64.
15. Bahubeshi A, Bal N, Rio Frio T, et al. Germline DICER1 mutations and familial cystic nephroma. J Med Genet 2010;47: 863-6.
16. Rio Frio T, Bahubeshi A, Kanellopoulou C, et al. DICER1 mutations in familial multinodular goitre with and without ovarian Sertoli-Leydig cell tumors. JAMA 2011;305:68-77.
17. Foulkes WD, Bahubeshi A, Hamel N, et al. Extending the phenotypes associated with DICER1 mutations. Hum Mut 2011;32:1381-4.
18. Hutton SM, Webster LR, Nielsen S, et al. Immunohistochemical expression and prognostic significance of oestrogen receptor-a, oestrogen receptor-b, and progesterone receptor in stage 1 adult-type granulosa cell tumour of the ovary. Pathology 2012;44:611-6.
19. Stewart CJR, Doherty D, Guppy R, et al. Beta-catenin and Ecadherin expression in stage 1 adult-type granulosa cell tumour of the ovary: correlation with tumour morphology and clinical outcome. Histopathology 2013;62:257-66.
20. Rabban JT, Zaloudek CJ. A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours. Histopathology 2013;62:71-88.
21. Bahubeshi A, Tischkowitz M, Foulkes WD. miRNA processing and human cancer: DICER1 cuts the mustard. Sci Transl Med 2011;3:111ps46. doi:10.1126/scitranslmed.3002493 Available at http://www.ncbi.nlm.nih.gov/pubmed/?term=bahubesi +foulkes+mustard+DICER1.
22. Kim MS, Lee SH, Yoo NJ, et al. DICER1 exons 25 and 26 mutations are rare in common human tumours besides Sertoli-Leydig cell tumour. Histopathology 2013;63: 436-8.
23. Schultz K, Pacheco M, Yang J, et al. Ovarian sex cord-stromal tumours, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry. Gynecol Oncol 2011;122:246-50.
24. Kommoss S, Anglesio MS, Mackenzie R, et al. FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines. Mod Pathol 2013;26:860-7.
25. Kommoss S, Gilks CB, Penzel R, et al. A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary. Histopathology 2014; 64:380-8.
26. Zhao C, Barner R, Vinh TN, et al. SF-1 is a diagnostically useful immunohistochemical marker and comparable to other sex cord-stromal tumor markers for the differential diagnosis of ovarian Sertoli cell tumor. Int J Gynecol Pathol 2008;27: 507-14.
27. Al-Agha OM, Huwait HF, Chow C, et al. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol 2011;35:484-94.
28. Portugal R, Oliva E. Calretinin: diagnostic utility in the female genital tract. Adv Anat Pathol 2009;16:118-24.